Sonal Singh to Tiotropium Bromide
This is a "connection" page, showing publications Sonal Singh has written about Tiotropium Bromide.
Connection Strength
0.678
-
Singh S, Loke YK, Enright P, Furberg CD. Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Postgrad Med J. 2014 Apr; 90(1062):205-7.
Score: 0.115
-
Singh S, Loke YK, Enright P, Furberg CD. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Thorax. 2013 Jan; 68(1):114-6.
Score: 0.102
-
Singh S, Loke YK, Enright PL, Furberg CD. Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials. BMJ. 2011 Jun 14; 342:d3215.
Score: 0.094
-
Singh S, Furberg CD. Inhaled anticholinergics for chronic obstructive pulmonary disease: comment on "Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease". Arch Intern Med. 2011 May 23; 171(10):920-2.
Score: 0.094
-
Singh S, Loke YK, Furberg CD. Outpatient management of severe COPD. N Engl J Med. 2010 07 29; 363(5):493-4; author reply 494-5.
Score: 0.089
-
Singh S, Furberg CD, Loke YK. Tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2009 Jan 08; 360(2):186; author reply 187.
Score: 0.080
-
Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008 Sep 24; 300(12):1439-50.
Score: 0.078
-
Beasley R, Singh S, Loke YK, Enright P, Furberg CD. Call for worldwide withdrawal of tiotropium Respimat mist inhaler. BMJ. 2012 Nov 09; 345:e7390.
Score: 0.026